TY - CHAP AU - Berek, J. S. AU - Natarajan, S. ED - Rerek, J. S. PY - 2007 DA - 2007// TI - Ovarian and fallopian tube cancer BT - Berek and Novak's Gynecology PB - Lippincott Williams and Wilkins CY - Philadelphia ID - Berek2007 ER - TY - JOUR AU - Su, R. M. AU - Chang, K. C. AU - Chou, C. Y. PY - 2003 DA - 2003// TI - Signet-ring stromal tumor of the ovary: a case report JO - Int J Gynecol Cancer VL - 13 UR - https://doi.org/10.1136/ijgc-00009577-200301000-00017 DO - 10.1136/ijgc-00009577-200301000-00017 ID - Su2003 ER - TY - JOUR AU - El-Safadi, S. AU - Stahl, U. AU - Tinneberg, H. R. AU - Hackethal, A. AU - Muenstedt, K. PY - 2010 DA - 2010// TI - Primary signet ring cell mucinous ovarian carcinoma: a case report and literature review JO - Case Rep Oncol VL - 3 UR - https://doi.org/10.1159/000323003 DO - 10.1159/000323003 ID - El-Safadi2010 ER - TY - JOUR AU - Ogawa, S. AU - Inoue, S. AU - Ogiwara, S. AU - Kitamura, C. AU - Kawarabayashi, Y. AU - Ichinoe, A. PY - 2012 DA - 2012// TI - A case of primary signet ring cell carcinoma of the ovary JO - The J Fukuoka College Obstet Gynecol VL - 36 ID - Ogawa2012 ER - TY - JOUR AU - Jaya Ganesh, P. AU - Vimal Chander, R. AU - Kachana, M. P. AU - Narasimhan, L. PY - 2014 DA - 2014// TI - Primary ovarian mucinous carcinoma with signet ring cells - report of a rare case JO - J Clin Diagn Res VL - 8 ID - Jaya Ganesh2014 ER - TY - JOUR AU - Kim, J. H. AU - Cha, H. J. AU - Kim, K. R. AU - Kim, K. PY - 2018 DA - 2018// TI - Primary ovarian signet ring cell carcinoma: a rare case report JO - Mol Clin Oncol VL - 9 ID - Kim2018 ER - TY - JOUR AU - Ozols, R. F. AU - Bundy, B. N. AU - Greer, B. E. AU - Fowler, J. M. AU - Clarke-Pearson, D. AU - Burger, R. A. AU - Mannel, R. S. AU - DeGeest, K. AU - Hartenbach, E. M. AU - Baergen, R. PY - 2003 DA - 2003// TI - Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a gynecologic oncology group study JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.02.153 DO - 10.1200/JCO.2003.02.153 ID - Ozols2003 ER - TY - JOUR AU - Bois, A. AU - Lück, H. J. AU - Meier, W. AU - Adams, H. P. AU - Möbus, V. AU - Costa, S. PY - 2003 DA - 2003// TI - Arbeitsgemeinschaft Gynäkologische Onkologie ovarian Cancer study group. A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer JO - J Natl Cancer Inst VL - 95 UR - https://doi.org/10.1093/jnci/djg036 DO - 10.1093/jnci/djg036 ID - Bois2003 ER - TY - JOUR AU - Krukenberg, F. PY - 1896 DA - 1896// TI - Uber das fibrosarcoma ovarii mucocellulare (carcinomatodes) JO - Arch Gynecol VL - 50 ID - Krukenberg1896 ER - TY - JOUR AU - Joshi, V. V. PY - 1968 DA - 1968// TI - Primary Krukenberg tumor of ovary. Review of literature and case report JO - Cancer VL - 22 UR - https://doi.org/3.0.CO;2-P DO - 3.0.CO;2-P ID - Joshi1968 ER - TY - JOUR AU - Shirasaka, T. AU - Shimamato, Y. AU - Ohshimo, H. AU - Yamaguchi, M. AU - Kato, T. AU - Yonekura, K. PY - 1996 DA - 1996// TI - Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators JO - Anti-Cancer Drugs VL - 7 UR - https://doi.org/10.1097/00001813-199607000-00010 DO - 10.1097/00001813-199607000-00010 ID - Shirasaka1996 ER - TY - JOUR AU - Koizumi, W. AU - Kurihara, M. AU - Nakano, S. AU - Hasegawa, K. PY - 2000 DA - 2000// TI - Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 cooperative gastric Cancer study group JO - Oncology VL - 58 UR - https://doi.org/10.1159/000012099 DO - 10.1159/000012099 ID - Koizumi2000 ER - TY - JOUR AU - Ohtsu, A. AU - Baba, H. AU - Sakata, Y. AU - Mitachi, Y. AU - Horikoshi, N. AU - Sugimachi, K. PY - 2000 DA - 2000// TI - Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 cooperative colorectal carcinoma study group JO - Br J Cancer VL - 83 UR - https://doi.org/10.1054/bjoc.2000.1236 DO - 10.1054/bjoc.2000.1236 ID - Ohtsu2000 ER - TY - JOUR AU - Ueno, H. AU - Okusaka, T. AU - Ikeda, M. AU - Takezako, Y. AU - Morizane, C. PY - 2005 DA - 2005// TI - An early phase II study of S-1 in patients with metastatic pancreatic cancer JO - Oncology VL - 68 UR - https://doi.org/10.1159/000086771 DO - 10.1159/000086771 ID - Ueno2005 ER - TY - JOUR AU - Perez, R. P. AU - Lewis, L. D. AU - Beelen, A. P. AU - Olszanski, A. J. AU - Johnston, N. AU - Rhodes, C. H. AU - Beaulieu, B. AU - Ernstoff, M. S. AU - Eastman, A. PY - 2006 DA - 2006// TI - Modulation of Cell Cycle Progression in Human Tumors: A Pharmacokinetic and Tumor Molecular Pharmacodynamic Study of Cisplatin Plus the Chk1 Inhibitor UCN-01 (NSC 638850) JO - Clinical Cancer Research VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-06-0197 DO - 10.1158/1078-0432.CCR-06-0197 ID - Perez2006 ER - TY - JOUR AU - Koizumi, W. AU - Narahara, H. AU - Hara, T. AU - Takagane, A. AU - Akiya, T. AU - Takagi, M. PY - 2008 DA - 2008// TI - S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial JO - Lancet Oncol VL - 9 UR - https://doi.org/10.1016/S1470-2045(08)70035-4 DO - 10.1016/S1470-2045(08)70035-4 ID - Koizumi2008 ER - TY - JOUR AU - Aoki, Y. AU - Ochiai, K. AU - Lim, S. AU - Aoki, D. AU - Kamiura, S. AU - Lin, H. PY - 2018 DA - 2018// TI - Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer JO - Br J Cancer VL - 119 UR - https://doi.org/10.1038/s41416-018-0206-7 DO - 10.1038/s41416-018-0206-7 ID - Aoki2018 ER -